1.21 USD
↘ 0.11 (8.33%)AT CLOSE (03:59 PM EDT)
Virax Biolabs Group Limited Ordinary Shares
VRAXNASDAQ • USD
1.21
↘ 0.00 (0.08%)
POST MARKET (AS OF 03:59 PM EDT)
Post Market
AS OF 03:59 PM EDT
1.21
↘ 0.00 (0.08%)
Market: CLOSED
VRAX is currently priced at $1.28. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 30, 2026.
Open?$1.29
High?$1.30
Low?$1.18
Prev. Close?$1.32
Volume?23.7K
Avg. Volume?N/A
VWAP?$1.26
Bid / Ask
Bid?$1.00 × 100
Ask?$1.41 × 100
Spread?$0.41
Midpoint?$1.21
Valuation & Ratios
Market Cap?1.8M
Shares Out?796.9K
Float?776.1K
Float %?97.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.16%Low
Short Interest?9.0K
Days to Cover?1.0
Free Float776.1K
Avg Daily Volume343.5K
Settlement Date2026-10-15